Patents by Inventor Mickey Pentecost

Mickey Pentecost has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230312678
    Abstract: Described herein are compositions and techniques related to generation and therapeutic application of artificial synapses. Artificial synapses are engineered extracellular vesicles, including exosomes, which incorporate sticky binders on their surface to anchor signaling domains against biological targets, such as receptors. These engineered additives can be organized in genetic vector constructs, expressed in mammalian cells, wherein the sticky binders attach to extracellular vesicles such as exosomes, thereby presenting their joined signaling domains which are rapidly taken up by recipient cells. Artificial synapses adopt the hallmark biophysical and biochemical features of extracellular vesicles, allowing for rapid deployment and scale-up. Importantly, this strategy can allow for kinetically favorable signal generation and signal propagation.
    Type: Application
    Filed: November 16, 2022
    Publication date: October 5, 2023
    Applicant: DIADEM BIOTHERAPEUTICS INC.
    Inventors: Mickey Pentecost, Wojciech Bartkowski
  • Patent number: 11746138
    Abstract: Described herein are compositions and techniques related to generation and therapeutic application of artificial synapses. Artificial synapses are engineered extracellular vesicles, including exosomes, which incorporate sticky binders on their surface to anchor signaling domains against biological targets, such as receptors. These engineered additives can be organized in genetic vector constructs, expressed in mammalian cells, wherein the sticky binders attach to extracellular vesicles such as exosomes, thereby presenting their joined signaling domains which are rapidly taken up by recipient cells. Artificial synapses adopt the hallmark biophysical and biochemical features of extracellular vesicles, allowing for rapid deployment and scale-up. Importantly, this strategy can allow for kinetically favorable signal generation and signal propagation.
    Type: Grant
    Filed: July 16, 2021
    Date of Patent: September 5, 2023
    Assignee: DIADEM BIOTHERAPEUTICS INC.
    Inventors: Mickey Pentecost, Wojciech Bartkowski
  • Patent number: 11578116
    Abstract: Described herein are compositions and techniques related to generation and therapeutic application of artificial synapses. Artificial synapses are engineered extracellular vesicles, including exosomes, which incorporate sticky binders on their surface to anchor signaling domains against biological targets, such as receptors. These engineered additives can be organized in genetic vector constructs, expressed in mammalian cells, wherein the sticky binders attach to extracellular vesicles such as exosomes, thereby presenting their joined signaling domains which are rapidly taken up by recipient cells. Artificial synapses adopt the hallmark biophysical and biochemical features of extracellular vesicles, allowing for rapid deployment and scale-up. Importantly, this strategy can allow for kinetically favorable signal generation and signal propagation.
    Type: Grant
    Filed: July 16, 2021
    Date of Patent: February 14, 2023
    Assignee: DIADEM BIOTHERAPEUTICS INC.
    Inventors: Mickey Pentecost, Wojciech Bartkowski
  • Publication number: 20220411481
    Abstract: Described herein are compositions and techniques related to generation and therapeutic application of artificial synapses. Artificial synapses are engineered extracellular vesicles, including exosomes, which incorporate sticky binders on their surface to anchor signaling domains against biological targets, such as receptors. These engineered additives can be organized in genetic vector constructs, expressed in mammalian cells, wherein the sticky binders attach to extracellular vesicles such as exosomes, thereby presenting their joined signaling domains which are rapidly taken up by recipient cells. Artificial synapses adopt the hallmark biophysical and biochemical features of extracellular vesicles, allowing for rapid deployment and scale-up. Importantly, this strategy can allow for kinetically favorable signal generation and signal propagation.
    Type: Application
    Filed: August 9, 2021
    Publication date: December 29, 2022
    Applicant: DIADEM BIOTHERAPEUTICS INC.
    Inventors: Mickey Pentecost, Wojciech Bartkowski
  • Publication number: 20210379198
    Abstract: Described herein are compositions and techniques related to generation and therapeutic application of artificial synapses. Artificial synapses are engineered extracellular vesicles, including exosomes, which incorporate sticky binders on their surface to anchor signaling domains against biological targets, such as receptors. These engineered additives can be organized in genetic vector constructs, expressed in mammalian cells, wherein the sticky binders attach to extracellular vesicles such as exosomes, thereby presenting their joined signaling domains which are rapidly taken up by recipient cells. Artificial synapses adopt the hallmark biophysical and biochemical features of extracellular vesicles, allowing for rapid deployment and scale-up. Importantly, this strategy can allow for kinetically favorable signal generation and signal propagation.
    Type: Application
    Filed: July 16, 2021
    Publication date: December 9, 2021
    Applicant: DIADEM BIOTHERAPEUTICS INC.
    Inventors: Mickey Pentecost, Wojciech Bartkowski
  • Publication number: 20210371497
    Abstract: Described herein are compositions and techniques related to generation and therapeutic application of artificial synapses. Artificial synapses are engineered extracellular vesicles, including exosomes, which incorporate sticky binders on their surface to anchor signaling domains against biological targets, such as receptors. These engineered additives can be organized in genetic vector constructs, expressed in mammalian cells, wherein the sticky binders attach to extracellular vesicles such as exosomes, thereby presenting their joined signaling domains which are rapidly taken up by recipient cells. Artificial synapses adopt the hallmark biophysical and biochemical features of extracellular vesicles, allowing for rapid deployment and scale-up. Importantly, this strategy can allow for kinetically favorable signal generation and signal propagation.
    Type: Application
    Filed: July 16, 2021
    Publication date: December 2, 2021
    Applicant: DIADEM BIOTHERAPEUTICS INC.
    Inventors: Mickey Pentecost, Wojciech Bartkowski
  • Publication number: 20190046576
    Abstract: Provided herein are lyophilized compositions containing the secretome of cultured adipose cells, pharmaceutical compositions and that additionally contain a sustained release drug delivery matrix, as well as methods of making and using such compositions.
    Type: Application
    Filed: February 13, 2017
    Publication date: February 14, 2019
    Applicant: Cell Care Therapeutics
    Inventors: Raja Shekhar Gangaraju, Nicolas Miroslav Jotterand Sohl, Veronique Hedwige Jotterand, Mickey Pentecost